Market research
ALMDT.PA Median Technologies SA
PA EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 226M
- P/E ratio
- Not available
- Analyst target
- 11.9667
- Dividend yield
- Not available
- Beta
- 0.51
Profile
Company facts
- Exchange
- PA
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- FR0011049824
- Market cap
- 226M
- P/E ratio
- Not available
- Analyst target
- 11.9667
- Dividend yield
- Not available
- Beta
- 0.51
About
About Median Technologies SA
Median Technologies SA develops and markets software solutions and services for the use of medical images for the diagnosis and monitoring of patients with cancer in Europe, North America, and Asia. The company offers iCRO, an imaging service for oncology clinical trials; and eyonis, an end-to-end CADe/CADx software as medical devices. The company was founded in 2002 and is based in Valbonne, France.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the ALMDT.PA discussion.
5 years, 4 months ago
Median Technologies SA is currently in a long term uptrend where the price is trading 24.0% above its 200 day moving average.
From a valuation standpoint, the stock is 94.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 14.7.
Based on the above factors, Median Technologies SA gets an overall score of 2/5.